Latest Etanercept Stories

Novel drug treatment facilitates recovery of memory, mood and cognitive function. The improved self-suficiency enables a lower level of care according to a recent NWC observational study. (PRWEB) May 22, 2013 Neurological Recovery Guide and Neurological Wellness Center have been facilitating recovery from Alzheimer's disease since 2010.This breakthrough therapy results in rapid cognitive improvement by reducing inflammation in the brain. A growing body of published research has linked...

Observational Study by Neurological Wellness Center Physicians Confirms Significant Recoveries with Perispinal Etanercept Administered Years After the Injury. (PRWEB) May 15, 2013 Neurological Recovery Guide and Neurological Wellness Center have been facilitating recovery from TBI since 2010.This research published in the Journal BMC Neuroscience and available online finds; "The TBI induced cerebral ischemia, neurological motor deficits,and increased numbers of microglia-TNF-alpha...

Comprehensive SARIL-RA development program to include 2,600 patients in four Phase 3 and one open-label extension trials PARIS and TARRYTOWN, N.Y., May 15, 2013 /PRNewswire/ -- Sanofi (EURONEXT: SAN and NYSE: SNY) and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the COMPARE and ASCERTAIN trials of sarilumab, the first fully human monoclonal antibody directed against the IL-6 receptor, which is delivered by subcutaneous injection every other week, have enrolled...

Neurological Wellness Center Responds to a Recent Report; “Brain Injury Awareness Month: New Hope for the Brain-Injured Person.”* (PRWEB) May 08, 2013 Neurological Recovery Guide and Neurological Wellness Center have been facilitating recovery from traumatic brain injury since 2010. March was Brain Injury Awareness Month. Traumatic Brain Injury (TBI) is a serious problem in the United States according to this article in the Huffington Post. 1.7 million Americans will experience a...

Ilaris® (canakinumab) is the first interleukin-1 beta inhibitor for the treatment of SJIA and the only treatment approved specifically for SJIA that is given as a monthly subcutaneous injection(1) EAST HANOVER, N.J., May 10, 2013 /PRNewswire/ -- Novartis announced today that the US Food and Drug Administration (FDA) has approved Ilaris(®) (canakinumab) for the treatment of active systemic juvenile idiopathic arthritis (SJIA) in patients aged 2 years and older. Ilaris is the...

Neurological Wellness Center to launch a clinical trial of perispinally administered etanercept as an Alzheimer's disease treatment. (PRWEB) May 01, 2013 Neurological Recovery Guide and Neurological Wellness Center have been facilitating recovery from Alzheimer's disease since 2010. Although the precise causes of Alzheimer's Disease are still unknown, there is a growing body of evidence linking chronic inflammatory events in the brain with the onset and progression of AD....

Neurological Wellness Center Comments on Alzheimer’s Care Assisted Living Expenses Costing $90 to $200 Per Day According to a Recent Article in the Los Angeles Times* (PRWEB) April 17, 2013 Implementing the treatment detailed in Perispinal etanercept: a new therapeutic paradigm in neurology by Dr. Tobinick can enable a severely impaired person needing full time assisted living care who is unable to recognize their own children or even count to ten to, after a single dose, recognize...

The 14-minute segment that aired on 60 Minutes Australia features a man, Charlie Giales, with severe Alzheimer’s receiving a perispinal injection of the drug Enbrel. Within minutes of receiving this injection, Charlie regains his mental faculties. (PRWEB) April 10, 2013 This 60 Minute show, which aired October 16, 2011, powerfully demonstrates that Alzheimer’s disease no longer has to be the long good-bye that it was for Ronald Reagan. Substantial recovery of memory and cognitive...

Three new studies review use, comparative effectiveness and cost SAN DIEGO, April 4, 2013 /PRNewswire/ -- In recent years, biologic anti-inflammatory (BAI) specialty medications used to treat autoimmune inflammatory conditions such as rheumatoid arthritis (RA), psoriasis and Crohn's disease, have seen double-digit percentage price increases. The potential exists to treat many more patients than are currently receiving a BAI medication, according to new studies presented today by...

Neurological Wellness Center physicians call on Floridians in the Fort Lauderdale area to participate in a clinical trial utilizing perispinally administered etanercept as an Alzheimer's disease treatment. (PRWEB) April 03, 2013 To enroll in this no cost clinical trial please visit blog.lef.org/2012/01/arthritis-drug-for-alzheimers-patients.html or call: 866-517-4536 between 9AM and 5PM ET. Neurological Wellness Center physicians have been treating Alzheimer's disease with low...